These studies identify PDK2/4 as a metabolic checkpoint for M1 phenotype polarization of macrophages, which could potentially be exploited as a novel therapeutic target for obesity-associated metabolic disorders and other inflammatory conditions. The gene discussed is PDK2; the disease is obesity due to melanocortin 4 receptor deficiency.